- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RAS Mutation
Total 82228 results
-
PTC TherapeuticsCompleted
-
Greater Baltimore Medical CenterCompleted
-
Institute of Cancer Research, United KingdomCancer Research UKTerminated
-
Centre Georges Francois LeclercAstraZenecaTerminatedNon-small Cell Lung Cancer MetastaticFrance
-
M.D. Anderson Cancer CenterUnknownKidney Cancer | Colorectal Cancer | Bladder Cancer | Skin Cancer | Endometrial Cancer | Uterus CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMLH1 Gene Mutation | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Metastatic Carcinoma in the Liver | MSH6 Gene Mutation | PMS2 Gene MutationUnited States
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)Completed
-
Lei LiUnknownEpithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | ChineseChina
-
National Institute of Diabetes and Digestive and...CompletedDiabetes Mellitus | Insulin Resistance | Abnormal Glucose MetabolismUnited States
-
Azienda Ospedaliero-Universitaria CareggiUnknown
-
Samsung Medical CenterCompletedBenign Prostatic HyperplasiaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Ohio State University Comprehensive Cancer CenterCompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Ductal Breast Carcinoma in Situ | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States
-
Mayo ClinicCompleted
-
Blokhin's Russian Cancer Research CenterUnknownOvarian Neoplasms | Ovarian Cancer | Chemotherapy | BRCA1 Mutation | BRCA2 Mutation | Serous AdenocarcinomaRussian Federation
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Ovarian Epithelial TumorUnited States
-
Novartis PharmaceuticalsCompletedTumors With CDK4/6 Pathway ActivationUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedRenal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Endometrial Carcinoma | Stage III Bladder Cancer | Cervical Squamous Cell Carcinoma | Stage IV Breast Cancer | Malignant Uterine Neoplasm | Recurrent Bladder Carcinoma | Recurrent... and other conditionsUnited States
-
AstraZenecaRUSSCO (Russian Society of Clinical Oncology)CompletedOvarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in RussiaRussian Federation
-
Samsung Medical CenterCompleted
-
Samsung Medical CenterCompletedGastric CancerKorea, Republic of
-
University Hospital, MontpellierCompletedCancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer
-
Spirita Oncology, LLCTerminatedAML | MDS | CMMLUnited States
-
University of Roma La SapienzaAzienda Ospedaliero, Universitaria PisanaUnknownPancreatic CancerItaly, Ireland
-
Zai Lab (Shanghai) Co., Ltd.Completed
-
Placon TherapeuticsUnknownBreast Neoplasms | Prostatic Neoplasms | Pancreatic Neoplasms | Ovarian NeoplasmsUnited States
-
AHMED ABDULQADER HAMMOUDA ABOU SHALLAssiut University; Kuwait UniversityUnknown
-
University of FloridaDriverWithdrawn
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Terminated
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
Sheba Medical CenterUnknownHereditary Breast and Ovarian Cancer SyndromeIsrael
-
National Heart, Lung, and Blood Institute (NHLBI)Terminated
-
National Cancer Institute (NCI)Glaxosmithkline Biologicals S.A.TerminatedRenal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic ComplicationUnited States, Canada
-
National Human Genome Research Institute (NHGRI)Completed
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditionsUnited States
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Memorial Sloan Kettering Cancer CenterWithdrawnMelanoma | Gastric Cancer | Non-Hodgkin's Lymphoma | Lung Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer | Uterine Cancer | CORPUS UTERI,ENDOMETRIUM | LUNG | OVARYUnited States
-
National Health Research Institutes, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital; Taipei Veterans General... and other collaboratorsUnknownColorectal Cancer | Drug Resistance | Mass Spectrometry | RAS-RAF Pathway DeregulationTaiwan
-
Women and Infants Hospital of Rhode IslandCompletedOvarian Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseTerminatedOvarian CancerUnited States
-
Hadassah Medical OrganizationTerminated
-
AbbVieCompletedBreast Cancer | Hepatocellular Carcinoma | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Melanoma | Primary Peritoneal Cancer | Non-hematologic Malignancies